Doximity, Inc.

NYSE:DOCS

58.85 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q3
Revenue 138.288168.603136.832126.676118.057135.284113.612108.469110.966115.262102.18590.63993.65397.87679.3572.66966.68758.70945.11336.38836.35432.426
Cost of Revenue 14.46714.18113.67613.5512.56712.1912.75913.15313.67713.52613.2113.07711.76511.0858.9517.9867.9937.8727.4567.8754.2813.78
Gross Profit 123.821154.422123.156113.126105.49123.094100.85395.31697.289101.73688.97577.56281.88886.79170.39964.68358.69450.83737.65728.51332.07328.646
Gross Profit Ratio 0.8950.9160.90.8930.8940.910.8880.8790.8770.8830.8710.8560.8740.8870.8870.890.880.8660.8350.7840.8820.883
Reseach & Development Expenses 24.80322.42123.2422.57420.14819.94619.95821.93121.54120.51919.10419.02217.42416.22515.4613.24112.55811.4069.86610.0438.8918.605
General & Administrative Expenses 12.72713.58510.1039.2559.9739.6418.9669.2479.7599.5138.7498.72410.6449.0798.8277.1965.7034.4783.2093.1021.7681.954
Selling & Marketing Expenses 37.61138.49134.36735.24433.33434.50430.20134.45533.14833.2229.02128.13425.89925.69821.16119.37117.58617.01714.14513.28510.35210.669
SG&A 50.33852.07644.4744.29743.30744.59739.16743.70242.90742.73337.7736.85836.54334.77729.98826.56723.28921.49517.35416.38712.1212.623
Other Expenses 002.30400.18307.93603.8752.4610.9080.804-0.0160.02-0.02-0.031-0.2634.601-0.093-0.2900
Operating Expenses 75.14174.49770.01467.07363.63864.54367.06165.63364.44863.25256.87455.8853.96751.00245.44839.80835.84732.90127.2226.4322.21721.265
Operating Income 48.6879.92553.14246.05341.85258.55133.79229.68332.84138.48432.10121.68227.92135.78924.95124.87522.84717.93610.4372.08311.0627.418
Operating Income Ratio 0.3520.4740.3880.3640.3550.4330.2970.2740.2960.3340.3140.2390.2980.3660.3140.3420.3430.3060.2310.0570.3040.229
Total Other Income Expenses Net 9.7149.9159.0297.1166.1014.4815.9034.8393.8752.4610.9080.804-0.0160.020.420.0450.0384.601-0.02-0.153-0.8860.325
Income Before Tax 58.39489.8462.17153.16947.95363.03239.69534.52236.71640.94533.00922.48627.90535.80925.37124.9222.88522.53710.4171.9310.1767.743
Income Before Tax Ratio 0.4220.5330.4540.420.4060.4660.3490.3180.3310.3550.3230.2480.2980.3660.320.3430.3430.3840.2310.0530.280.239
Income Tax Expense -4.06414.64418.01711.7927.33515.0769.0936.1166.0487.4776.710.103-8.821-19.838-10.717-1.4021.4025.3060.380.4712.7071.84
Net Income 62.45875.19644.15441.37740.61847.95630.60228.40630.66833.46826.29922.38336.72655.64736.08826.32221.48317.23110.0371.4593.5145.903
Net Income Ratio 0.4520.4460.3230.3270.3440.3540.2690.2620.2760.290.2570.2470.3920.5690.4550.3620.3220.2930.2220.040.0970.182
EPS 0.330.40.240.220.220.260.160.150.160.170.120.120.170.30.190.120.250.0360.0110.010.0450.072
EPS Diluted 0.310.370.220.210.20.240.150.130.140.160.120.10.170.260.170.090.190.0320.010.010.0430.072
EBITDA 48.6882.5853.14247.51744.461.0644.33237.66339.96138.48432.10121.68229.57535.78924.95124.87524.29718.45111.3652.85111.3647.617
EBITDA Ratio 0.3520.490.3880.3750.3760.4510.390.3470.360.3340.3140.2390.3160.3660.3140.3420.3640.3140.2520.0780.3130.235